Professional Documents
Culture Documents
Classes Class 1A Slower Categories Names Na blockers Phase 0 blockers Actions Uses Mainly ventricular arrhythmias SVT (Supraventricular Tachycardia) Side effect Can aggravate / precipitate (new) arrhythmias Quinidine : headache, tinnitus, dizziness, blurred vision Procainamide : Lupus like effect (arthralgia/arthritis) Disopyramide : atropine (antimuscarinic) like effects, may cause CHF Lidocaine: Mainly neurologic side effects Mexiletine: Tremor, blurred vision, lethargy, nausea Quinidine Prolong APD Procainamide Prolong repolarization Disopyramide Depress conduction & prolong refractory period Negative inotropic Prolong QRS (ECG)
Class 1B Faster
Na blockers
Effects only on depolarized / rapidly firing tissue Decrease APD and ERP (HisPurkinje; ventricles) Increase ventricular fibrillation threshold digitalis induced afterdepolarizations (Phenytoin) Suppresses abnormal automaticity (Flecainide) Slows conduction (AV node, Ventricles) atrial/ventricular refractoriness (Propafenone)
Class 1C Slower
Na blockers
Ventricular arrhythmias ( esp. post MI) Lidocaine: IV (rapid action, not proarrhythmic) Mexiletine: Oral Phenytoin: digitalis induced arrhythmias Ventricular arrhythmias ( esp. post MI) Flecainide: PVCs Propafenone: Supravenricular arrhythmias
Both: Exacerbation of ventricular arrhythmias (sp. Flec) Flecainide: Negative inotropic effect Propafenone: Metallic taste, constipation
Class 2 Slower
sympathetic stimulation + membrane stabilization - Reduce automaticity in SAN and Purkinje fibres - Slow conduction and ERP in SA node - APD and ERP in atria & ventricles Block outward K+ current during repolarization Prolong repolarization Prolong APD and ERP Sotalol (class II + Class III
Ventricular arrhythmias (post MI) Supraventricular tachycardia Tachycardia associated with thyrotoxicosis Atrial Fibrillation Recurrent ventricular tachyarrhythmias
Bronchospasm (avoid in asthmatics) Hypotension / fatigue / exercise intolerance CNS effects : sleep disturbances (sp. Propranolol)
Class 3 Slower
Amiodarone many adverse effects not recommended as first line drug Heart: Symptomatic bradycardia and heart block Lung: Pulmonary fibrosis Liver: hepatitis Thyroid: blocks peripheral conversion of T4 to T3 Skin: photosensitivity, dermatitis, discolouration Eye: corneal microdeposits Constipation Beware: combination with blockers / digoxin
Class 4 Slower
Block L-type voltage gated Ca++ channels - both activated and inactivated states blocked - affect conduction in SA and AV nodes - prolong APD and ERP (AV nodal) - suppress early & delayed after-depolarizations
Mainly supraventricular tachycardia (preferred drug) Atrial fibrillation & flutter (to slow ventricular rate)
Digoxin Slower
Others
Acts through adenosine receptors Directly inhibits AV nodal conduction & ERP (less effect on SA node) Inhibits Na-K ATPase Increases force of contraction Vagotonic Blocks AV conduction Slows ventricular rate in AF
USE: Atrial fibrillation (to slow the ventricular rate) (Also used in heart failure inotropic action)